Alzheimer's disease drug discovery

Alzheimer’s disease is the most common cause of age-related dementia. Alzheimer’s disease presents with irreversible cognitive decline, which commences as insidious short-term memory dysfunction and gradually spreads to other cognitive domains, rendering patients mute and non-ambulatory after 10-15...

Descripción completa

Detalles Bibliográficos
Otros Autores:	Huang, Xudong (Editor), Huang, Xudong, editor (editor)
Formato:	Libro electrónico
Idioma:	Inglés
Publicado:	Australia Exon Publications 2020 Brisbane, Australia : [2020]
Materias:	Alzheimer's disease. Etiology of Alzheimer’s Disease; Epidemiology of Alzheimer’s Disease; Neuropathology of Alzheimer’s Disease; Pathogenesis of Alzheimer’s Disease; Immunotherapy for Alzheimer’s Disease; Amyloid β-Targeted Inhibitory Peptides for Alzheimer’s Disease; Tau Protein-Targeted Therapies in Alzheimer’s Disease; Targeting Metal Homeostasis for Alzheimer’s Disease; Insulin-Resistant in Alzheimer’s Disease; Blood–Brain Barrier in Alzheimer’s Disease; Epigenetic Modifications in Alzheimer’s Disease; Chimeric Conjugates for Alzheimer’s Disease; Multifunctional Ligand Approach for Alzheimer’s Disease; Natural Products for Alzheimer’s Disease
Ver en Biblioteca Universitat Ramon Llull:	https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009622265006719